Amanote Research
Register
Sign In
Engineering Escherichia Coli NfsB to Activate a Hypoxia-Resistant Analogue of the PET Probe EF5 to Enable Non-Invasive Imaging During Enzyme Prodrug Therapy
doi 10.1021/acs.biochem.9b00376.s001
Full Text
Open PDF
Abstract
Available in
full text
Date
Unknown
Authors
Unknown
Publisher
American Chemical Society (ACS)
Related search
18f-Ef5 PET Imaging as an Early Response Biomarker for the Hypoxia-Activated Prodrug SN30000 Combined With Radiation Treatment in a Non-Small Cell Lung Cancer Xenograft Model
Journal of Nuclear Medicine
Medicine
Nuclear Medicine
Radiology
Imaging
Characterization of NfsB, the Minor Oxygen-Insensitive Nitroreductase of Escherichia Coli
Multimodal PET/MRI Imaging Results Enable Monitoring the Side Effects of Radiation Therapy
Contrast Media and Molecular Imaging
Medicine
Nuclear Medicine
Radiology
Imaging
CRP Interacts Specifically With Sxy to Activate Transcription in Escherichia Coli
Frontiers in Microbiology
Microbiology
Conversion of Escherichia Coli RNA Polymerase to a Template Independent Enzyme
Nucleic Acids Research
Genetics
PET Imaging of Tumour Hypoxia
Cancer Imaging
Nuclear Medicine
Radiology
Ultrasound Technology
Oncology
Radiological
Imaging
Medicine
PDEPT: Polymer-Directed Enzyme Prodrug Therapy
British Journal of Cancer
Cancer Research
Oncology
Image-Guided Enzyme/Prodrug Cancer Therapy
Clinical Cancer Research
Cancer Research
Oncology
Invasive Strains of Escherichia Coli Belonging to Serotype O121:NM.
Journal of Clinical Microbiology
Microbiology
